Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.
Glia. 2020 Sep;68(9):1910-1924. doi: 10.1002/glia.23814. Epub 2020 Feb 28.
As oligodendrocyte precursor cells (OPCs) are vulnerable to ischemia, their differentiation to oligodendrocytes (OLG) is impaired in chronic cerebral hypoperfusion. Astrocyte-OLG interaction is important for white matter homeostasis. Recently, reactive astrocytes were separated into two types, A1 (cytotoxic) and A2 (neurotrophic). However, their role in prolonged cerebral hypoperfusion remains unclear. We analyzed the effects of interaction between A1-A2 astrocytes and OPC-OLG under hypoperfusion, focusing on mitochondrial migration. As an in vivo model, chronic hypoperfusion model mice were created by bilateral common carotid artery stenosis (BCAS) using microcoils. As a matching in vitro study, rat primary cells were cocultured with a nonlethal concentration of CoCl . At 28 days after hypoperfusion, the number of OPC and astrocytes increased, whereas that of OLG decreased. Increased astrocytes were mainly A1-like astrocytes; however, the number of A2-like type decreased. In cell culture, OPC differentiation was interrupted under mimic chronic ischemia, but improved after astrocyte-conditioned medium (ACM) was added. However, injured-ACM was unable to improve OPC maturation. Incubation with CoCl changed astrocytes from A2-like to A1-like, and mitochondrial migration was also reduced. A Trkβ agonist was able to maintain astrocytes from A1-like to A2-like even under hyperperfused conditions, and aided in OPC maturation and memory impairment via mitochondrial migration and drug effects in cell culture study and BCAS model. The reduction of A1-like astrocytes protects against white matter injury. Trkβ agonists may play an important role in the impairment under chronic ischemic conditions. Mitochondrial migration may be a broad therapeutic strategy for cerebrovascular diseases. MAIN POINTS: Prolonged cerebral hypoperfusion leads to impaired oligodendrocyte (OLG) maturation and increased numbers of A1 astrocytes. Mitochondria migration maintained A2 astrocyte morphology, mature OLG, and myelinated white matter in vivo/vitro.
由于少突胶质前体细胞(OPC)对缺血敏感,因此慢性脑灌注不足会损害其向少突胶质细胞(OLG)的分化。星形胶质细胞-OLG 相互作用对于维持白质稳态很重要。最近,反应性星形胶质细胞被分为两种类型,A1(细胞毒性)和 A2(神经营养型)。然而,它们在长期脑灌注不足中的作用尚不清楚。我们分析了在灌注不足下 A1-A2 星形胶质细胞与 OPC-OLG 之间相互作用的影响,重点研究了线粒体迁移。作为体内模型,通过微线圈对双侧颈总动脉狭窄(BCAS)的小鼠创建慢性低灌注模型。作为一项匹配的体外研究,用非致死浓度的 CoCl2 对大鼠原代细胞进行共培养。低灌注 28 天后,OPC 和星形胶质细胞的数量增加,而 OLG 的数量减少。增加的星形胶质细胞主要是 A1 样星形胶质细胞;然而,A2 样类型的数量减少。在细胞培养中,模拟慢性缺血会中断 OPC 分化,但添加星形胶质细胞条件培养基(ACM)后可改善。然而,受损的 ACM 无法改善 OPC 成熟。用 CoCl2 孵育将星形胶质细胞从 A2 样转变为 A1 样,线粒体迁移也减少。Trkβ 激动剂即使在高灌注条件下也能使星形胶质细胞保持 A2 样,通过细胞培养研究和 BCAS 模型中的线粒体迁移和药物作用来促进 OPC 成熟和记忆障碍。减少 A1 样星形胶质细胞可防止白质损伤。Trkβ 激动剂在慢性缺血条件下的损伤中可能发挥重要作用。线粒体迁移可能是脑血管疾病的广泛治疗策略。主要观点:长时间的脑灌注不足会导致少突胶质细胞(OLG)成熟受损和 A1 星形胶质细胞数量增加。线粒体迁移在体内/体外维持 A2 星形胶质细胞形态、成熟的 OLG 和髓鞘化的白质。